Since the release of "Keba Article", the refinancing of the first unprofitable enterprise in Shanghai Stock Exchange has been approved, and Dizhe Medicine announced that the company's private placement plan has been approved by Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article". (science and technology innovation board Daily)Diplomat: The EU envoy failed to reach an agreement on the 15th round of sanctions against Russia.The China Securities Association held a meeting of directors and all members of the regional equity market professional committee, and the meeting of directors and all members of the regional equity market professional committee of the Securities Association was held in Chongqing on December 5th. The regional equity market should further thoroughly implement the spirit of the Third Plenary Session of the 20th CPC Central Committee, take the new "National Nine Articles" as a guide, persist in comprehensively deepening reforms, strive to break down institutional and institutional obstacles and structural problems, explore innovative pilot projects according to local conditions, develop new quality productivity, and establish a basic service system, a comprehensive financial service system and a listing standard cultivation system that are in line with local conditions and the characteristics of small and medium-sized enterprises, so as to continuously improve the comprehensive financial service capability. At the same time, the positioning function of regional equity market is still in the exploration stage, and innovation exploration in various places should pay attention to both standardization and development, and various risk prevention and control and supporting measures should be in place simultaneously.
The USD/JPY intraday increase of USD/JPY expanded to 0.50% and is now reported at 152.72.Light Media: "Nezha's Devil's Boy Makes a Sea" has rich derivatives planning. Light Media said on the interactive platform that at present, the company's IP derivative business is advancing normally. "Nezha's Devil Kids Roaring the Sea" has been planned and will launch derivative products with rich categories and wide price range in due course, including tide play, handcrafted products, statues, cards, stationery, food play, badges, billboards, publications, plush products and daily necessities, which can meet the diverse needs of different groups of people.Song Zhexie, Samsung Semiconductor: I feel the great potential of the semiconductor market in China and I am very willing to grow with China customers. At the Shanghai IC Industry Development Forum 2024 held today, Song Zhe Xie, general manager of Samsung Semiconductor Foundry Greater China, said that the semiconductor industry in China is not only growing in scale, but also improving the development quality of the whole industry from the product upgrading and process evolution of Samsung semiconductor customers. The development of new quality productivity is helping the semiconductor market in China to flourish. In the cooperation with customers in China, I feel the great potential of the semiconductor market in China, and I am very willing to grow with customers in China, and provide diversified solutions to meet the needs of customers in China to enhance the competitiveness of products.
India's new central bank governor: we must be vigilant and flexible to the challenges we face.Since the release of "Keba Article", the refinancing of the first unprofitable enterprise in Shanghai Stock Exchange has been approved, and Dizhe Medicine announced that the company's private placement plan has been approved by Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article". (science and technology innovation board Daily)The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13